An investigation into the relationship between sleep-disordered breathing, the metabolic syndrome, cardiovascular risk profiles, and inflammation between South Asians and Caucasians residing in the United Kingdom

Metabolic Syndrome and Related Disorders

Volumn 10, Issue 2, 2012, Pages 152-158

  Brady, Emer M ^a   Davies, Melanie J ^b   Hall, Andrew P ^a   Talbot, Duncan C S ^c   Dick, Joanne L ^c   Khunti, Kamlesh ^b  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNILEVER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANTHROPOMETRY; ARTICLE; ASIAN; BERLIN SLEEP QUESTIONNAIRE; BODY FAT DISTRIBUTION; CARDIOVASCULAR RISK; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ETHNICITY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SLEEP DISORDERED BREATHING; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM; WAIST CIRCUMFERENCE;

ADULT; AGED; ASIA, SOUTHEASTERN; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GREAT BRITAIN; HUMANS; INFLAMMATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RESIDENCE CHARACTERISTICS; RISK FACTORS; SLEEP APNEA SYNDROMES;

EID: 84858841897     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2011.0073     Document Type: Article

References (33)

1. Tishler PV, Larkin EK, Schluchter MD, et al. Incidence of sleep-disordered breathing in an urban adult population: The relative importance of risk factors in the development of sleep-disordered breathing. JAMA 2003;289:2230-2237.
2. Zamarron C, Gude F, Otero Y, et al. Prevalence of sleep disordered breathing and sleep apnea in 50-to 70-year-old individuals. A survey. Respiration 1999;66:317-322.
3. Shinohara E, Kihara S, Yamashita S, et al. Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med 1997;241: 11-18.
4. Endeshaw YW, Bloom HL, Bliwise DL. Sleep-disordered breathing and cardiovascular disease in the Bay Area Sleep Cohort. Sleep 2008;31:563-568.
5. Wolk R, Kara T, Somers VK. Sleep-disordered breathing and cardiovascular disease. Circulation 2003;108:9-12.
6. Chami HA, Resnick HE, Quan SF, et al. Association of incident cardiovascular disease with progression of sleepdisordered breathing. Circulation 123:1280-1286.
7. Young T, Peppard PE. Clinical presentation of OSAS: Gender does matter. Sleep 2005;28:293-295.
8. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: Evidence in support of current National Institutes of Health guidelines. Arch Intern Med 2002;162:2074-2079.
9. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: An update. Clin Endocrinol (Oxf) 2006;64: 355-365.
10. Schafer H, Pauleit D, Sudhop T, et al. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 2002;122:829-839.
11. Haffner SM. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. Obesity (Silver Spring) 2006;14(Suppl 3):121S-127S.
12. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004;27: 813-823.
13. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: Relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000;85:1151-1158.
14. Grundy SM, Hansen B, Smith SC, Jr., et al. Clinical management of metabolic syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004;109: 551-556.
15. World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications. Geneva, Switzerland: World Health Organization, 1999. Available at www.who.int/diabetes/currentpublications/en/. Accessed December 31, 2011.
16. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-A new worldwide definition. Lancet 2005;366:1059-1062.
17. Ilanne-Parikka P, Eriksson JG, Lindstrom J, et al. Prevalence of the metabolic syndrome and its components: Findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care 2004;27: 2135-2140.
18. Meigs JB, Wilson PW, Nathan DM, et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003;52: 2160-2167.
19. Gholap N, Davies M, Patel K, et al. Type 2 diabetes and cardiovascular disease in South Asians. Prim Care Diabetes 5:45-56.
20. Misra A, Vikram NK. Insulin resistance syndrome (metabolic syndrome) and obesity in Asian Indians: Evidence and implications. Nutrition 2004;20:482-491.
21. Ramachandran A, Snehalatha C, Vijay V. Low risk threshold for acquired diabetogenic factors in Asian Indians. Diabetes Res Clin Pract 2004;65:189-195.
22. Webb DR, Khunti K, Srinivasan B, et al. Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening. Trials 2010;11:16.
23. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-1428.
24. Netzer NC, Stoohs RA, Netzer CM, et al. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999;131:485-491.
25. Abate N, Chandalia M, Snell PG, et al. Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men. J Clin Endocrinol Metab 2004;89:2750-2755.
26. Nieto FJ, Peppard PE, Young TB. Sleep disordered breathing and metabolic syndrome. WMJ, 2009, 108:263-265.
27. Coughlin SR,Mawdsley L,Mugarza JA, et al. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004;25:735-741.
28. Hoffstein V, Mateika S. Cardiac arrhythmias, snoring, and sleep apnea. Chest 1994;106:466-471.
29. ArztM, Young T, Finn L, et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005;172:1447-1451.
30. Babu AR, Herdegen J, Fogelfeld L, et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005;165:447-452.
31. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73.
32. Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: A regulator of inflammation. Best Pract Res Clin Endocrinol Metab 2005;19:547-566.
33. The IDF Task Force on Epidemiology and Prevention. The IDF Consensus Statement on Sleep Apnoea and Type 2 Diabetes, 2008. Available at www.idf.org/sleep-apnoea-andtype-2-diabetes/. Accessed December 31, 2011.